BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
HCI
HCI Group, Inc.
HCI has the edge over BAC overall, supported by stronger valuation and stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HCI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
HCI's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HCI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
HCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7.7x | $191 | — |
| Cheap | 8.8x | $217 | +14% |
| Forward | 9.3x | $191 | — |
| Fair | 15x | $382 | +100% |
| Expensive | 30x | $752 | +294% |
Historical ranges are pointers, not guarantees.
HCI has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over HCI on the outlook, with more favorable valuation and earnings expectations.
HCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect HCI's revenue to grow, but its profitability to weaken.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
HCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.61 | -17% |
| Q3 2026 | $24.75 | +58% |
| Q2 2026 | $23.20 | +106% |
| Q1 2026 | $22.78 | +120% |
| Q4 2025 | $22.68 | +158% |
| Q3 2025 | $15.66 | +31% |
| Q2 2025 | $11.28 | -12% |
| Q1 2025 | $10.34 | +5.2% |
| Q4 2024 | $8.80 | +16% |
HCI earned $24.75 per share over the past year, up 58% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
HCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.9M | +13% |
| Q2 2026 | $246.7M | +11% |
| Q1 2026 | $242.9M | +12% |
| Q4 2025 | $246.2M | +52% |
| Q3 2025 | $216.4M | +23% |
| Q2 2025 | $221.9M | +7.6% |
| Q1 2025 | $216.4M | +4.8% |
| Q4 2024 | $161.9M | -0.5% |
HCI's revenue has grown year over year for seven quarters in a row: $245M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +5.6 points |
| Q2 2026 | 45% | +2.5 points |
| Q1 2026 | 48% | +1.1 points |
| Q4 2025 | 58% | +55 points |
| Q3 2025 | 42% | +34 points |
| Q2 2025 | 43% | +5.7 points |
| Q1 2025 | 46% | +8.9 points |
| Q4 2024 | 3.6% | -30 points |
HCI has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over HCI on cash flow, with more consistent year-over-year improvement.
HCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.5M | +188% |
| Q2 2026 | $124.8M | -14% |
| Q1 2026 | $148.5M | -7.4% |
| Q4 2025 | $110.2M | +50% |
| Q3 2025 | $25.9M | -75% |
| Q2 2025 | $144.5M | +$174.6M |
| Q1 2025 | $160.3M | -11% |
| Q4 2024 | $73.6M | -52% |
HCI's free cash flow was $458M over the past year, up 13% from the year before. Free cash flow isn't a meaningful measure for financial services companies like HCI.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HCI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -95K shares |
| 1 year | -2.6% | -329K shares |
| 3 years | +42% | +3.7M shares |
HCI has 13M diluted shares, down 2.6% from a year ago, with $81M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.5M |
| Q2 2026 | $57M |
| Q1 2026 | $17.5M |
| Q4 2025 | $800,000 |
| Q3 2025 | $37,000 |
| Q2 2025 | $48,000 |
| Q1 2025 | $639,000 |
| Q4 2024 | — |
HCI spent $81M buying back its own shares over the past year, more than ten times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.7x | Net Cash |
| Q3 2025 | -3.2x | Net Cash |
| Q2 2025 | -4.1x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -2.7x | Net Cash |
HCI has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 51.9 | Neutral |
HCI's weekly RSI is 55 (neutral) and its Stochastic is 52 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
HCI PE vs Financial Services Sector
| Metric | HCI | Sector median | Relative |
|---|---|---|---|
| PE | 7.7x | 13x | 41% below |
| PE % | 9 | 63 | 54 pts below |
HCI has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $191.0 | 0.1% below |
| 20 week MA | $186.4 | 2.4% above |
| 50 week MA | $173.3 | 10% above |
| 100 week MA | $162.9 | 17% above |
| 200 week MA | $122.1 | 56% above |
HCI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.9 | $51.8 | +13% |
| 2021 | $51.8 | $87.5 | +69% |
| 2022 | $87.5 | $39.6 | -55% |
| 2023 | $39.6 | $87.4 | +121% |
| 2024 | $87.4 | $117.4 | +34% |
| 2025 | $117.4 | $192.1 | +64% |
| 2026 YTD | $192.1 | $190.8 | -0.6% |
HCI has the edge over BAC on returns for 2026, with the stronger performance.